Skip to main content
. Author manuscript; available in PMC: 2021 May 28.
Published in final edited form as: Am J Obstet Gynecol. 2020 Sep 24;224(1):54–61. doi: 10.1016/j.ajog.2020.09.036

TABLE 3.

Management of hidradenitis suppurativa by disease severity

Disease severity Treatment type Treatment names52
Mild to moderate Antiseptic washes Benzoyl peroxide, chlorhexidine
Topical treatments Clindamycin, dapsone, resorcinola
Oral antibioticsb Clindamycin, dapsone, doxycycline,a,c metronidazole, minocycline,a moxifloxacin, rifampin
Hormonal therapies Oral contraceptives,a finasteride,a metformin, spironolactonea
Alternative medicine53 Magnesium sulfate salt bath, oral vitamin D, oral zinc
Procedures Deroofing (surgical or CO2 laser), intralesional triamcinolone, incision and drainage (for acute relief only given high recurrence rates), local excision, Nd:YAG laser
Moderate to severe Biologics TNF-α inhibitors, adalimumab,d infliximab; interleukin (IL)-1 antagonist, anakinra; IL-12 and IL-23 inhibitor, ustekinumab; IL-23 inhibitor, guselkumab; IL-17 inhibitor, secukinumab
Systemic antibiotics Ertapenem
Systemic immunosuppressants and immunomodulators Apremilast, colchicine, cyclosporine, systemic steroids
Retinoids Acitretin,a isotretinoina,e
Procedures CO2 laser excision, wide surgical excision, deroofing

Nd:YAG laser, neodymium-doped yttrium aluminum garnet laser; TNF-α, tumor necrosis factor alpha.

a

If not pregnant or actively trying to get pregnant

b

Combinations of oral antibiotics may be used, such as clindamycin 300 mg twice a day+rifampin 300 mg twice a day (up to 12 weeks)52; rifampin+moxifloxacin+metronidazole (up to 8 weeks)

c

Up to 100 mg twice a day52

d

The only Food and Drug Administration–approved therapy for hidradenitis suppurativa

e

Mixed results in the literature.54

Collier. Hidradenitis suppurativa and women’s health. Am J Obstet Gynecol 2021.